Skip to main content

Table 1 Clinical characteristics of recipients with and without Post Transplant Erythrocytosis

From: Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation

Clinical Variable

ALL (n = 1123)

No PTE (n = 1048)

PTE (n = 75)

P value

Recipients Characteristics

 Mean age (Years)

53.6 (13.2)

54.0 (13.2)

48.3 (11.1)

< 0.001

 African American race

524 (47%)

496 (47%)

28 (37%)

0.09

 Mean BMI (kg/m2)

28.3 (5.6)

28.4 (5.6)

27.2 (5.5)

0.06

 Gender (Male)

687 (61%)

628 (60%)

59 (79%)

0.001

 Cause of ESRD

Diabetes

355 (32%)

330 (31%)

25 (33%)

< 0.001

Hypertension

313 (28%)

294 (28%)

19 (25%)

Glomerulonephritis

182 (16%)

171 (16%)

11 (15%)

PKD

67 (6%)

54 (6%)

13 (17%)

Graft failure

91 (8%)

87 (8%)

4 (5%)

Other or unknown

115 (6%)

54 (5%)

13 (17%)

 Mean dialysis vintage (Months)a

53.4 (43.5)

53.6 (44.0)

51.2 (35.9)

0.86

 History of prior KT

158 (14%)

151 (14%)

7 (9%)

0.22

 Mean number of Human Leukocyte Antigen (HLA) mismatches (A,B,DR)

4.37 (1.33)

4.38 (1.34)

4.21 (1.08)

0.07

 Mean calculated PRA

21.0 (35)

21.5 (35.3)

14.2 (29.1)

0.14

Donor Characteristics

 Mean age (Years)

41.5 (15.3)

41.9 (15.3)

36.32 (13.6)

0.002

 African American race

179 (16%)

167 (16%)

12 (16%)

0.98

 Mean height (cm)

170.7 (11.1)

170.5 (11.2)

173.9 (9.7)

0.02

 Mean weight (kg)

82.5 (22.3)

82.5 (22.4)

82.1 (20.0)

0.76

 History of diabetes

117 (10%)

116 (11%)

1 (1%)

0.008

 History of hypertension

347 (31%)

335 (32%)

12 (16%)

0.004

 Donation after circulatory death (DCD)

215 (19%)

199 (19%)

16 (21%)

0.61

 History of hepatitis C

30 (3%)

26 (2%)

4 (5%)

0.13

 Cerebrovascular death

395 (35%)

377 (36%)

18 (24%)

0.03

 Mean terminal serum creatinine (mg/dL)

1.21 (0.93)

1.2 (0.9)

1.31 (1.37)

0.82

  1. Continuous variables: Wilcoxon rank sum or Kruskal-Wallis tests, and categorical variables were compared with chi-square tests or Fisher exact tests
  2. BMI Body Mass Index, PKD Polycystic Kidney Disease, ESRD End Stage Renal Disease
  3. aFor non-preemptive KT